Skip to main content
Top
Published in: Critical Care 1/2019

Open Access 01-12-2019 | Heart Transplantation | Letter

Should ECMO be used in cardiogenic shock?

Authors: Orhan Gokalp, Koksal Donmez, Hasan Iner, Gamze Gokalp, Yuksel Besir, Nihan Karakas Yesilkaya, Levent Yilik, Ali Gurbuz

Published in: Critical Care | Issue 1/2019

Login to get access

Excerpt

We read the compilation of Hajjar et al. with interest [1]. Cardiogenic shock is the clinical expression of circulatory failure, because of left, right, or biventricular dysfunction. One of the most common applications to eliminate circulatory failure is the extracorporeal membrane oxygenation (ECMO), as stated by the authors. Theoretically, ECMO will provide the necessary circulatory support. However, it is unrealistic to expect ECMO to improve cardiac functions in a patient with cardiogenic shock. A veno-arterial (VA) ECMO that is applied in the case of a cardiogenic shock due to left ventricular (LV) failure is almost impossible to improve LV functions. Because, in order to improve myositis damage in a failing ventricle, the wall tension of the ventricle must be decreased. This is only possible by venting or in other words unloading the failing ventricle. However, it cannot be expected that the VA-ECMO can vent the left ventricle. …
Literature
2.
go back to reference Mebazaa A, Combes A, van Diepen S, et al. Management of cardiogenic shock complicating myocardial infarction. Intensive Care Med. 2018;44(6):760–73.CrossRefPubMed Mebazaa A, Combes A, van Diepen S, et al. Management of cardiogenic shock complicating myocardial infarction. Intensive Care Med. 2018;44(6):760–73.CrossRefPubMed
4.
go back to reference Muller G, Flecher E, Lebreton G, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med. 2016;42(3):370–8.CrossRefPubMed Muller G, Flecher E, Lebreton G, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med. 2016;42(3):370–8.CrossRefPubMed
5.
go back to reference Truby LK, Takeda K, Mauro C, et al. Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support. ASAIO J. 2017;63(3):257–65.CrossRefPubMed Truby LK, Takeda K, Mauro C, et al. Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support. ASAIO J. 2017;63(3):257–65.CrossRefPubMed
7.
go back to reference Pappalardo F, Schulte C, Pieri M, et al. Concomitant implantation of Impella (R) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. 2017;19:404–12.CrossRefPubMed Pappalardo F, Schulte C, Pieri M, et al. Concomitant implantation of Impella (R) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. 2017;19:404–12.CrossRefPubMed
8.
go back to reference Tehrani BN, Truesdell AG, Sherwood MW, et al. Standardized team-based care for cardiogenic shock. J Am Coll Cardiol. 2019;73:1659–69.CrossRefPubMed Tehrani BN, Truesdell AG, Sherwood MW, et al. Standardized team-based care for cardiogenic shock. J Am Coll Cardiol. 2019;73:1659–69.CrossRefPubMed
Metadata
Title
Should ECMO be used in cardiogenic shock?
Authors
Orhan Gokalp
Koksal Donmez
Hasan Iner
Gamze Gokalp
Yuksel Besir
Nihan Karakas Yesilkaya
Levent Yilik
Ali Gurbuz
Publication date
01-12-2019

Other articles of this Issue 1/2019

Critical Care 1/2019 Go to the issue